Bone Tissue Disorders: Healing Through Coordination Chemistry

Abstract

Osteoporosis, Paget's disease and osteosarcoma are a few examples of bone tissue disorders that affect millions of people worldwide. These conditions can strictly limit the lifestyle of patients and may even lead to their demise. To prevent this or, at least, try to manage the situation, there are several treatments available on the market. Notwithstanding, research has been driven by the possibility to improve the existing therapies, as well as to find new approaches that could better respond to these diseases. In this Review the path is shown through which, in recent years, coordination compounds have been prepared and manufactured to be applied in the management of bone tissue disorders. Starting with the design and preparation of the coordination compounds with various dimensionalities, two approaches have been used: (1) they are prepared as three‐dimensional cages that can act as delivery systems for therapeutic substances, or (2) they are constructed/prepared from compounds with intrinsic therapeutic properties. Following this, several strategies have been explored to manufacture the effective delivery to the patients. The versatility of coordination compounds has allowed their use in the preparation of drug tablets, coatings for titanium implants, or even scaffolds for bone tissue engineering. In the end, it becomes clear that these compounds can be a valuable approach to reach a better treatment for bone tissue disorders. Nonetheless, along the road, a few bumps have appeared concerning the therapeutic profile, such as the effect of the structural arrangement or particle size.

Metal–Organic Frameworks as Sensors for Human Amyloid Diseases

“… 33 Research on their biomedical applications has gained traction in the past decade, 34 mostly resulting from their astonishing structural properties, 35 which include permanent porosity, exceptional specific surface areas, tailorable pore size/structure, versatile modifications, and biocompatibility. 36 By virtue of these chemical and physical attributes, they have attracted tremendous interest as sensitive platforms for anchoring diverse probes (e.g., antibodies, DNA, or aptamers) for the construction of biosensors. 37 The integration of biomacromolecules within MOFs is typically achieved following mostly three simple strategies involving bioconjugation (outer surface covalent attachment or adsorption induced by the electrostatic interactions to the MOF), infiltration inside the pores via diffusion processes, and encapsulation during MOF synthesis.…”

“…MOFs in general have received increased attention on account of their potential application in a wide variety of fields, such as adsorption, environment, storage, separation, and sensing . Research on their biomedical applications has gained traction in the past decade, mostly resulting from their astonishing structural properties, which include permanent porosity, exceptional specific surface areas, tailorable pore size/structure, versatile modifications, and biocompatibility . By virtue of these chemical and physical attributes, they have attracted tremendous interest as sensitive platforms for anchoring diverse probes (e.g., antibodies, DNA, or aptamers) for the construction of biosensors .…”

Porphyrin NanoMetal-Organic Frameworks as Cancer Theranostic Agents

“…The development of materials with controlled structures and properties has created a plethora of prospects for disease diagnostics and therapy, particularly in oncology [ 1 , 2 , 3 ]. In recent years, much has been explored and discussed concerning the importance of the size and morphology of designed materials being highly associated with their biological performance, such as cellular uptake, cytotoxicity, biodistribution and blood circulation [ 4 , 5 ]. This is particularly relevant for those materials developed in the nanoscale dimension, whose unique physicochemical properties boost their biomedical applications [ 6 , 7 , 8 , 9 ].…”